Immukin

Interferon gamma-1b, the active ingredient in Immukin, is an interferon presented as a lyophilized powder for subcutaneous injection. It acts as an immunomodulator that enhances macrophage activity and promotes a Th1‑biased immune response, and it is indicated for patients with chronic granulomatous disease and severe malignant osteopetrosis.

GNH USA supplies Immukin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company ensures stringent quality assurance and maintains cold‑chain logistics to preserve product stability.

Immukin (interferon gamma‑1b) targets immune dysregulation in rare genetic and bone‑remodeling disorders. - Chronic granulomatous disease (CGD): enhances phagocyte killing capacity, reducing infection frequency. - Severe malignant osteopetrosis: modulates abnormal bone remodeling and supports hematopoiesis. - Mendelian susceptibility to mycobacterial disease (MSMD): improves host defense against mycobacterial infections.

Interferon gamma‑1b may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Flu‑like symptoms: chills, muscle aches, and malaise. - Injection‑site reactions: redness, swelling, or pain at the injection site. - Fever: transient elevation of body temperature. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Autoimmune hepatitis: liver inflammation with elevated enzymes. - Hematologic abnormalities: neutropenia or thrombocytopenia.

When using Immukin, several precautions should be observed to ensure safety and maintain product efficacy. - Monitor blood counts: regular CBC to detect neutropenia or thrombocytopenia. - Assess hepatic function: check liver enzymes before and during therapy. - Screen for autoimmune disease: avoid in patients with active autoimmune disorders. - Avoid in severe renal impairment without dose adjustment. - Pregnancy and lactation: use only if potential benefit justifies risk; data are limited. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Interferon gamma‑1b can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Live vaccines: may diminish vaccine efficacy or cause infection. - High‑dose corticosteroids: can blunt immunomodulatory effect. - Immunosuppressants (e.g., azathioprine): increase risk of infection.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): may enhance anticoagulant effect, monitor INR. - CYP450 substrates: interferon may affect metabolism of certain drugs; observe therapeutic levels. - Thyroid hormones: interferon can alter thyroid function; monitor thyroid tests.